Danaher Stock News

This portfolio strategy uses the quarterly 13F filings to extract 50 consensus stocks from 40 large hedge funds that have more than $3.5 billion Assets Under Management.

A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates.

Boeing, Apple and Salesforce and Wells Fargo among the Club holdings that are moving Friday.

In the latest trading session, Danaher (DHR) closed at $281.40, marking a +1.25% move from the previous day.

All stocks have at least five fiscal years of dividend growth history and come from the U.S. Dividend Champions List.

Someone with a lot of money to spend has taken a bearish stance on Danaher (NYSE: DHR ). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don''t know. But when something this big happens with DHR, it often means somebody knows something is about to happen. Today, Benzinga''s options scanner spotted 10 options trades for Danaher . This isn''t normal. The overall sentiment of these big-money traders is split between 30% bullish and 70%, bearish. Out of all of the options we uncovered, there was 1 … Full story available on Benzinga.com

BOSTON , March 14, 2022 /PRNewswire/ -- Below is the February 2022 Monthly Update for the Liberty All-Star Growth Fund, Inc. (NYSE: ASG ) Liberty All-Star Growth Fund, Inc. Ticker: ASG Monthly Update, February, 2022 Investment Approach: Fund Style: All-Cap Growth Fund Strategy: Combines three growth style investment managers, each with a distinct capitalization focus (small-, mid- and large-cap) selected and continuously monitored by the Fund''s Investment Advisor. Investment Managers: Weatherbie Capital, LLC Small-Cap Growth Congress Asset Management Company, LLP Mid-Cap Growth Sustainable Growth Advisers, LP Large-Cap Growth Top 20 Holdings at Month-End (31.6% of equity portfolio) 1 SPS Commerce, Inc. 2.5% 2 Amazon.com, Inc. 2.2% 3 UnitedHealth Group, Inc. 1.9% 4 Casella Waste Systems, Inc. 1.8% 5 Microsoft Corp. 1.8% 6 Visa, Inc. 1.7% 7 FirstService Corp. 1.7% 8 SiteOne Landscape Supply, Inc. 1.7% 9 Chegg, Inc. 1.6% 10 Globant SA 1.5% 11 StepStone Group, Inc. 1.4% 12 Danaher Corp. Full story available on Benzinga.

Strategy of selecting 10 of 50 stocks, equally weighted, would have increased total return to 188.6%. Here we report most recent holdings and trading signals for 3/14/2021.

Danaher (DHR) closed the most recent trading day at $262.52, moving -0.5% from the previous trading session.

Danaher (DHR) closed the most recent trading day at $263.83, moving -0.37% from the previous trading session.

We''re selling one name, Amazon, that''s up on a largely immaterial announcement, and buying another, Danaher, that''s down on no news.

Sector ETF report for IHI

Danaher Corp (DHR) Presents at Cowen Health Care Broker Conference (Transcript)

Danaher Corporation with ticker code (DHR) have now 19 analysts covering the stock. The analyst consensus points to a rating of ''Buy''. The target price ranges between 400 and 302 with the average target price sitting at 342.92. With the stocks previous close at 272.54 this is indicating there is a potential upside of 25.8%. The 50 day moving average now sits at 289.29 while the 200 day moving average is 295.42. The company has a market cap of $188,152m. Visit the company website at: https://www.danaher.com [stock_market_widget type="chart" template="basic" color="green" assets=DHR" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $236,740m based on the market concensus. Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy.